Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global reproductive genetics market size reached US$ 5.1 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 24.8 Billion by 2028, exhibiting a growth rate (CAGR) of 30.2% during 2022-2028. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.
Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.
Reproductive Genetics Market Trends:
The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.
Key Market Segmentation:
Product Type Insights:
- Kits
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Insights:
- Carrier Screening
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
Technology Insights:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- In Situ Hybridization (ISH/FISH)
- Microarray
Application Insights:
- Aneuploidy
- Structural Chromosomal Abnormality
- Single Gene Disorder
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Companies Mentioned
- Bangkok Genomics Innovation Public Company Limited
- Centogene N.V.
- Fulgent Genetics Inc.
- Igenomix (Vitrolife Group)
- Invitae Corporation
- Laboratory Corporation of America Holdings
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/2u7nhv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
